Guillain-Barré Syndrome after H1N1 Vaccination in the United States: A Report Using the CDC/FDA Vaccine Adverse Event Reporting System (2009)

Publisher： Karger

E-ISSN： 1423-0208|38|4|227-232

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.38, Iss.4, 2012-04, pp. : 227-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guillain-Barré Syndrome after H1N1 Influenza: A Concern

By  

Neuroepidemiology, Vol. 40, Iss. 4, 2013-03 ,pp. : 295-295

Karger

Access to resources Recommend Favorite

Guillain-Barré Syndrome Incidence in a Large United States Cohort (2000–2009)

By  

Neuroepidemiology, Vol. 39, Iss. 2, 2012-07 ,pp. : 109-115

Karger

Access to resources Recommend Favorite

Hospital Admissions for Guillain-Barré Syndrome in the United States, 1993–2004

By  

Neuroepidemiology, Vol. 29, Iss. 1-2, 2009-05 ,pp. : 83-88

Karger

Access to resources Recommend Favorite

‘Hyperacute’ Guillain-Barré Syndrome

By  

European Neurology, Vol. 59, Iss. 1-2, 2007-10 ,pp. : 88-90

Karger

Access to resources Recommend Favorite

Successful Treatment of Guillain-Barré Syndrome with Combined Administration of Interferon-β-1a and Intravenous Immunoglobulin

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 167-168

Karger

Access to resources Recommend Favorite